Your browser doesn't support javascript.
loading
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease.
Gonzales, Mitzi M; Garbarino, Valentina R; Kautz, Tiffany; Palavicini, Juan Pablo; Lopez-Cruzan, Marisa; Dehkordi, Shiva Kazempour; Mathews, Julia; Zare, Habil; Xu, Peng; Zhang, Bin; Franklin, Crystal; Habes, Mohamad; Craft, Suzanne; Petersen, Ronald C; Tchkonia, Tamara; Kirkland, James; Salardini, Arash; Seshadri, Sudha; Musi, Nicolas; Orr, Miranda E.
Afiliación
  • Gonzales MM; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Garbarino VR; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Kautz T; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Palavicini JP; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Lopez-Cruzan M; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Dehkordi SK; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Mathews J; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Zare H; Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Xu P; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Zhang B; Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Franklin C; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Habes M; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Craft S; Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Petersen RC; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tchkonia T; Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kirkland J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Salardini A; Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Seshadri S; Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Musi N; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Orr ME; Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Res Sq ; 2023 Apr 24.
Article en En | MEDLINE | ID: mdl-37162971

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos